News

Metagenomi Inc. (NASDAQ:MGX) is one of the best young stocks to buy and hold for 5 years. In mid-May, Metagenomi announced ...
In a nutshell Researchers successfully restored hearing in 10 deaf participants aged 18 months to 24 years using gene therapy ...
Using AI and Multiplexed Gene Fragments, researchers developed a novel design approach to encode thousands of single-domain ...
The UK's health secretary has announced a 10-year plan to check newborns for a huge range of rare conditions. There are major ...
Backed by filmmaker Peter Jackson, scientists at Colossal Biosciences are using cutting-edge genetic technology to attempt ...
It’s time to step up the opposition to designer babies, says Marcy Darnovsky of the Center for Genetics and Society ...
A novel gene therapy designed to target a form of inherited deafness restored hearing function in five children who were ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
In a major step forward for autism research, diagnostics, and patient care, researchers have found four distinct autism subtypes,... | Genetics And Genomics ...
The FDA granted orphan drug designation to Sineugene Therapeutics' SNUG01, a first-in-class experimental gene therapy for ...
In a comprehensive Genomic Press Interview published in Brain Medicine, Dr. Michael C. Oldham shares his unconventional journey from advertising executive to computational neuroscientist and his ...